Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia

Published:2022-06-20 Issue:9 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Morton Jedidiah I.¹²³^ORCID,Ilomӓki Jenni²³,Magliano Dianna J.¹²,Shaw Jonathan E.¹²

Affiliation:

1. Baker Heart and Diabetes Institute Melbourne Victoria Australia

2. School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia

3. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria Australia

Funder

State Government of Victoria

National Health and Medical Research Council

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14898

Reference25 articles.

1. Medical costs associated with type 2 diabetes complications and comorbidities;Li R;Am J Manag Care,2013

2. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

3. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

4. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

5. The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of, time to, and type of first add‐on anti‐hyperglycaemic therapy to metformin in Australia, 2018–2022;British Journal of Clinical Pharmacology;2024-09-03

2. Excess Risk of Injury in Individuals With Type 1 or Type 2 Diabetes Compared With the General Population;Diabetes Care;2024-06-25

3. Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia;Diabetes, Obesity and Metabolism;2024-04-15

4. The effect of frailty on post-discharge management and outcomes of acute glycaemic crises: Analysis of admissions for hypoglycaemia and hyperglycaemia in Australia;Diabetes Research and Clinical Practice;2024-03

5. Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019;American Journal of Kidney Diseases;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3